TNNT2 and myocardial infarction: In an ISO-induced myocardial infarction model, administration of Hecogenin was shown to significantly reduce serum levels of cardiac injury biomarkers, including creatine kinase-MB (CK-MB), cardiac troponin T (cTnT), and cardiac troponin I (cTnI).